Polarean Imaging plc

Equities

POLX

GB00BF3DT583

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 11:35:26 2024-07-04 am EDT			5-day change	1st Jan Change
1.7 ^GBX	-1.45%		-7.61%	-72.80%

Jun. 28	EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	AN
Jun. 28	Polarean Imaging plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Polarean Imaging plc Reports Earnings Results for the Full Year Ended December 31, 2023

June 28, 2024 at 02:00 am EDT

Polarean Imaging plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.890933 million compared to USD 1.03 million a year ago. Sales was USD 0.890933 million compared to USD 1.03 million a year ago.

Net loss was USD 11.88 million compared to USD 13.91 million a year ago. Net loss was USD 11.88 million compared to USD 13.91 million a year ago. Basic loss per share from continuing operations was USD 0.055 compared to USD 0.066 a year ago.

Basic loss per share from continuing operations was USD 0.055 compared to USD 0.066 a year ago.

Latest news about Polarean Imaging plc

EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	Jun. 28	AN
Polarean Imaging plc Reports Earnings Results for the Full Year Ended December 31, 2023	Jun. 28	CI
Powerhouse resolves claim; PCI-PAL wins court case	May. 22	AN
Polarean Imaging Seeks $10 Million from Share Sale	May. 22	MT
Polarean Imaging to raise USD10 million via placing and subscription	May. 21	AN
Polarean Imaging Wins Order for Xenon MRI System in US	May. 10	MT
FTSE 100 hits record high on BoE vote, UK GDP	May. 10	AN
Polarean shares soar on University of Alabama deal for Xenon MRI	May. 10	AN
AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing	May. 10	AN
Polarean Imaging plc Receives Second De Novo Order for A New Xenon MRI System from the University of Alabama At Birmingham Hospital	May. 10	CI
Polarean Imaging wins order for new polariser	May. 03	AN
Polarean Imaging Wins Order for Hyperpolarization System in US	May. 03	MT
Polarean Imaging plc Receives Order for Upgraded Hyperpolariser	May. 03	CI
Nexteq confident of meeting full-year expectations	Apr. 16	AN
Polarean Imaging Secures New Patent for Hyperpolarized Imaging Platform	Apr. 16	MT
Polarean Imaging shares sink after announcing a costly strategic plan	Feb. 29	AN
Polarean Imaging strategic parter raises stake to above 10%	Jan. 15	AN
Nukem Isotopes Ups Polarean Imaging Stake	Jan. 15	MT
Polarean shares jump on Xenoview polariser order	Dec. 07	AN
AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean	Dec. 07	AN
Polarean Imaging Plc Receives First De Novo Order for A New XENOVIEWtm Polariser	Dec. 07	CI
Polarean Imaging Teams up with Vida Diagnostics on Magnetic Resonance Imaging Platform	23-09-08	MT
Polarean Imaging partners with Vida Diagnostics on MRI solutions	23-09-08	AN
Polarean Imaging plc Partnership with VIDA Diagnostics, Inc. to Streamline Adoption of Advanced MRI of the Lungs	23-09-08	CI
FTSE 100 Closes Up 0.21% on Pound Weakness	23-09-07	DJ

Chart Polarean Imaging plc

Duration

Period

More charts

Company Profile

Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Companyâs technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Companyâs subsidiary is Polarean, Inc.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.0217 USD

Average target price

0.1021 USD

Spread / Average Target

+370.52%

Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
POLAREAN IMAGING PLC	-72.80%	26.58M
SARTORIUS AG	-32.56%	15B
QUIDELORTHO CORPORATION	-57.92%	2.08B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+20.62%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-26.04%	1.26B
BIOTAGE AB	+18.77%	1.22B
REVENIO GROUP OYJ	-0.44%	789M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-37.53%	720M
CONTEC MEDICAL SYSTEMS CO.,LTD	-39.55%	718M
VAREX IMAGING CORPORATION	-29.95%	587M

Medical Diagnostic & Testing Equipment